Association between Subjective Evaluation of Skin Toxicities and Quality of Life in Patients with Lung Cancer Undergoing Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor Treatment: A Pilot Study for Developing Skin Toxicity Assessment

Journals Menu

Follow SCIRP

Contact us

	+1 323-425-8868
	customer@scirp.org
	+86 18163351462(WhatsApp)
	1655362766

	Paper Publishing WeChat

Open Journal of Nursing

Open Journal of Nursing

Open Journal of Nursing

ISSN Print: 2162-5336
ISSN Online: 2162-5344
www.scirp.org/journal/ojn
E-mail: ojn@scirp.org

Google-based Impact Factor: 1.22
Citations

Journals Menu

"Association between Subjective Evaluation of Skin Toxicities and Quality of Life in Patients with Lung Cancer Undergoing Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor Treatment: A Pilot Study for Developing Skin Toxicity Assessment"
written by Kengo Hirayama, Ya Su, Yasuyuki Ikezawa, Megumi Chiba, Kenichiro Ito, Michiko Yuki,
published by Open Journal of Nursing, Vol.9 No.12, 2019

has been cited by the following article(s):

Google Scholar
CrossRef

[1]	Efficacy of treatment for acneiform eruptions related to epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) for non-small cell lung cancer …
	2021

[2]	Effects of nursing intervention combined with well-being therapy on the improvement of perioperative emotions and subjective well-being in lung cancer …
	Int J Clin Exp Med, 2021

[1]	Efficacy of treatment for acneiform eruptions related to epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) for non-small cell lung cancer (NSCLC) Medicine, 2021 DOI:10.1097/MD.0000000000023875

[2]	Efficacy of treatment for acneiform eruptions related to epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) for non-small cell lung cancer (NSCLC) Medicine, 2021 DOI:10.1097/MD.0000000000023875

[3]	Efficacy of treatment for acneiform eruptions related to epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) for non-small cell lung cancer (NSCLC) Medicine, 2021 DOI:10.1097/MD.0000000000023875

Follow SCIRP

Weibo

Contact us

	+1 323-425-8868
	customer@scirp.org
	+86 18163351462(WhatsApp)
	1655362766

	Paper Publishing WeChat

Free SCIRP Newsletters

Add your e-mail address to receive free newsletters from SCIRP.

Copyright © 2006-2025 Scientific Research Publishing Inc. All Rights Reserved.

Top

翻译：